WAFERGEN BIO-SYSTEMS | 0,090 Euro | 0,000 0 % | |
| WKN: A0MN9S ISIN: US93041P1003 Ticker-Symbol: AAF | Frankfurt | 25.05.12 | 17:33 Uhr |
Branche BiotechnologieAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten | Leser | Medien | |
|---|---|---|---|---|
| 27.04. | WaferGen Bio-systems, Inc. - 10-K/A, Annual Report | 17 | SEC Filings | |
| 16.04. | WaferGen Bio-systems Announces Open Format qPCR Platform and Strategic Realignment | 28 | PR Newswire | |
| FREMONT, Calif., April 16, 2012 /PRNewswire/ -- WaferGen Bio-systems, Inc. (OTCBB: WGBS.OB), a nano-scale qPCR Company, announced today a strategic realignment and new direction for the organization.... Mehr lesen zu: WaferGen Bio-systems Announces Open Format qPCR Platform and Strategic Realignment | ||||
| 12.03. | WaferGen Biosystems Names Ivan Trifunovich CEO | 53 | AFX News | |
| WASHINGTON (dpa-AFX) - WaferGen Biosystems Inc. (WGBS.OB), Monday said it
appointed Ivan Trifunovich as President, Chief Executive Officer, and Director.
In connection with Trifunovich's... Mehr lesen zu: WaferGen Biosystems Names Ivan Trifunovich CEO | ||||
| 12.03. | WaferGen Appoints Ivan Trifunovich President, CEO, and Director | 25 | PR Newswire | |
| FREMONT, Calif., March 12, 2012 /PRNewswire/ -- WaferGen Biosystems, Inc. (OTCBB:WGBS), an emerging genomic analysis company, today announced the appointment of Ivan Trifunovich, Ph.D., as President... Mehr lesen zu: WaferGen Appoints Ivan Trifunovich President, CEO, and Director | ||||
| 09.02. | WaferGen to Present at 14th Annual BIO CEO & Investor Conference; Presentation to be Webcast | 26 | PR Newswire | |
| FREMONT, Calif., Feb. 9, 2012 /PRNewswire/ --WaferGen Biosystems, Inc. (OTCBB: WGBS), an emerging genomic analysis company, today announced that the company will deliver its corporate presentation... Mehr lesen zu: WaferGen to Present at 14th Annual BIO CEO & Investor Conference; Presentation to be Webcast | ||||
| 18.01. | WaferGen Appoints Life Science Investors Scott R. Davidson and Joseph F. Pesce to Board of Directors | 38 | PR Newswire | |
| FREMONT, Calif., Jan. 18, 2012 /PRNewswire/ -- WaferGen Biosystems, Inc. (OTCBB:WGBS), an emerging genomic analysis company, today announced that Scott R. Davidson and Joseph F. Pesce... Mehr lesen zu: WaferGen Appoints Life Science Investors Scott R. Davidson and Joseph F. Pesce to Board of Directors | ||||
| 05.01. | WaferGen to Present Corporate Overview at 5th Annual OneMedForum San Francisco 2012 | 17 | PR Newswire | |
| FREMONT, Calif., Jan. 5, 2012 /PRNewswire/ -- WaferGen Biosystems, Inc. (OTCBB:WGBS), an emerging genomic analysis company, today announced that the company plans to deliver its corporate... Mehr lesen zu: WaferGen to Present Corporate Overview at 5th Annual OneMedForum San Francisco 2012 | ||||
| 08.12. | WaferGen to Present Corporate Overview at Oppenheimer Healthcare Conference | 28 | PR Newswire | |
| FREMONT, Calif., Dec. 8, 2011 /PRNewswire/ -- WaferGen Biosystems, Inc. (OTCBB:WGBS), an emerging genomic analysis company, today announced that the company plans to deliver its corporate... Mehr lesen zu: WaferGen to Present Corporate Overview at Oppenheimer Healthcare Conference | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| EPIGENOMICS AG | 1,832 | -1,51 % | Das sollten Sie jetzt unbedingt beachten bei Epigenomics! |
| PAION AG | 0,826 | -6,14 % | Paion: 20 Prozent Zuschlag |
| WILEX AG | 3,849 | +1,56 % | WILEX AG berichtet über Hauptversammlung 2012 |
| MEDIGENE AG | 1,211 | -1,30 % | Medigene: Wie weit geht die Rallye? |
| XOMA CORP | 1,883 | +0,53 % | U.S Patent System to Transform From "First to Invent" to "First to File" - AVI BioPharma and XOMA Look to Benefit / The Paragon Report Provides Stock Research on AVI BioPharma and XOMA |
Startseite • Nachrichten • Aktienkurse • Xetra-Orderbuch • Watchlist
Ad hoc-Mitteilungen • Chartanalysen • Nachrichten Börsen • Aktien-Empfehlungen
Branchen • Medien • Nachrichten-Archiv
Impressum | AGB | Disclaimer • Presse • Mediadaten
RSS-News von FinanzNachrichten.de kostenlos für Ihren Browser und Ihre Homepage
